LGND Past Earnings image   This LGND past earnings page last updated 8/10/2022
LGND Past Earnings
PeriodPast Earnings DateAdj. EPS
Q2 20228/8/20221.030
Q1 20225/4/20220.760
Q4 20212/17/20221.800
Q3 202111/9/20211.580
Q2 20217/29/20211.630
Q1 20215/3/20211.410
Q4 20202/3/20211.620
Q3 202010/30/20201.040
Q2 20208/3/20201.000
Q1 20205/6/20200.890
Q4 20192/6/20200.710
Q3 201911/5/20190.490
Q2 20197/30/20190.680
Q1 20195/2/20191.160
Q4 20182/7/20191.7
Q3 201811/8/20181.32
Q2 20188/6/20182.59
Q1 20185/8/20181.55
Q4 20172/21/20181.31
Q3 201711/9/20170.69
Q2 20178/7/20170.67
Q1 20175/9/20170.57
Q4 20162/23/20171.25
Q3 201611/3/20160.62
Q2 20168/4/20160.5
Q1 20165/4/20160.97
Q4 20152/10/20160.66
Q3 201511/9/20150.56
Q2 20158/4/20151.81
Q1 20155/11/20150.33
Q4 20142/9/20150.6
Q3 201410/27/20140.36
Q2 20148/4/20140.24
Q1 20145/7/20140.35
Q4 20132/11/20140.35
Q3 201310/30/20130.12
Q2 20138/1/20130.07
Q1 20135/8/20130.07
Q4 20122/13/20130.13
Q3 201211/5/2012-0.01
Q2 20128/8/2012-0.2
Q1 20125/2/20120.06
LGND Past Revenue
PeriodPast Earnings DateGAAP
Q2 20228/8/20220.06B
Q1 20225/4/20220.05B
Q4 20212/17/20220.07B
Q3 202111/9/20210.06B
Q2 20217/29/20210.08B
Q1 20215/3/20210.06B
Q4 20202/3/20210.07B
Q3 202010/30/20200.04B
Q2 20208/3/20200.04B
Q1 20205/6/20200.03B
Q4 20192/6/20200.03B
Q3 201911/5/20190.02B
Q2 20197/30/20190.02B
Q1 20195/2/20190.04B
Q4 20182/7/201959.59M
Q3 201811/8/201845.66M
Q2 20188/6/201890.04M
Q1 20185/8/201856.16M
Q4 20172/21/201850.46M
Q3 201711/9/201733.38M
Q2 20178/7/201728.00M
Q1 20175/9/201729.27M
Q4 20162/23/201738.19M
Q3 201611/3/201621.62M
Q2 20168/4/201619.52M
Q1 20165/4/201629.65M
Q4 20152/10/201621.19M
Q3 201511/9/201517.70M
Q2 20158/4/201518.42M
Q1 20155/11/201514.60M
Q4 20142/9/201523.00M
Q3 201410/27/201415.00M
Q2 20148/4/201410.61M
Q1 20145/7/201415.96M
Q4 20132/11/201414.70M
Q3 201310/30/201313.01M
Q2 20138/1/20139.58M
Q1 20135/8/201311.70M
Q4 20122/13/201313.64M
Q3 201211/5/20126.40M
Q2 20128/8/20125.70M
Q1 20125/2/20125.64M
Quotes delayed 20 minutes

Email EnvelopeFree LGND Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Ligand Pharmaceuticals (LGND) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

LGVN Past Earnings
LH Past Earnings
LHCG Past Earnings
LHDX Past Earnings
LIFE Past Earnings
LIXT Past Earnings
LJPC Past Earnings
LLY Past Earnings
LMAT Past Earnings
LMNX Past Earnings

LGND Past Earnings Q&A

What was the best and worst LGND past earnings results?
For Ligand Pharmaceuticals, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest LGND past earnings result in our data set was 2.59/share posted in Q2 2018, while the lowest was in Q2 2012 when LGND posted -0.2/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2018 when LGND reported 90.04M in revenue, while the quarter with the lowest revenue in our data set was Q1 2012 at 5.64M of revenue.

  Suggested answer: There are 42 LGND past earnings results in our data set.

On this page we presented the LGND past earnings date information for Ligand Pharmaceuticals. Reviewing that LGND Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2018, when LGND posted adjusted EPS of 2.59/share. Meanwhile the lowest LGND past earnings result was in Q2 2012, when LGND posted adjusted EPS of -0.2/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2018 when LGND reported 90.04M in revenue, while the smallest revenue quarter was Q1 2012 when LGND reported 5.64M in revenue.

Any self directed investor doing their due diligence on LGND or any other given stock can benefit from researching all of the Ligand Pharmaceuticals past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Ligand Pharmaceuticals past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for LGND. Thanks for visiting, and the next time you need to research LGND past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Institutional Holders of DJD, IO Insider Buying, OGS Stock Predictions.

 

LGND Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.